Immunotherapy based on repurposed drugs to combat ovarian cancer
KU Leuven
Belgium
Summary
Fully funded 4-year PhD in translational tumor immunology and immunotherapy for ovarian cancer via drug repurposing. Preclinical in vivo mouse work, immune analyses, and data integration to enable clinical translation. Interdisciplinary training with clinicians and pharmacologists.